Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003660384 | SCV004380488 | benign | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994573 | SCV004813820 | uncertain significance | not specified | 2024-02-29 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1E c.5791G>A (p.Gly1931Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249040 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.5791G>A in individuals affected with Epileptic Encephalopathy, Early Infantile, 69 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2784444). Based on the evidence outlined above, the variant was classified as uncertain significance. |